Key Highlights
• Hims & Hers Health (NYSE: HIMS) finalized a $400 million receivables purchase agreement with JPMorgan Chase Bank.
• The facility allows the company to sell eligible receivables at a discount, subject to JPMorgan’s discretion.
• An amendment to the existing credit agreement permits up to $400 million in additional indebtedness tied to the new facility.
• The agreement has an initial 364-day term, extendable annually with mutual consent.
Hims & Hers Health (NYSE: HIMS) has expanded its liquidity options through a new receivables financing arrangement with JPMorgan Chase Bank. The deal provides the telehealth and wellness company with a structured facility to monetize customer receivables, enhancing cash flow management.
Facility Terms Unveiled
The Master Receivables Purchase Agreement establishes a $400 million limit for eligible receivables. Under the terms, Hims & Hers may offer receivables to JPMorgan, which retains the right to decline purchases at its discretion. The arrangement includes a purchase discount applied to the face value of sold receivables.
Credit Agreement Amendment
On June 26, 2026, Hims & Hers amended its revolving credit agreement to accommodate the new facility. The amendment introduces a $400 million basket for permitted indebtedness tied to the receivables program. It also updates collateral provisions while leaving core loan terms, interest rates, and covenants unchanged.
Performance Guarantee
The company provided a Performance Undertaking effective July 1, 2026, guaranteeing its subsidiaries’ obligations under the agreement. The guarantee covers performance commitments but does not extend to receivables collectability or seller creditworthiness.
Duration and Flexibility
The receivables facility has an initial 364-day term, with options for annual extensions by mutual agreement. This structure offers Hims & Hers flexibility to adapt the program as business needs evolve.
Strategic Implications
The arrangement strengthens Hims & Hers’ working capital position without altering its existing debt structure. Investors may view the facility as a tool to optimize cash conversion cycles in its direct-to-consumer model.
Regulatory Filings
The agreements were disclosed in exhibits filed with the SEC, providing full legal details. The documents outline customary covenants, termination provisions, and default triggers for facilities of this type.
This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.





_11_20_2026_12_38_15_908731.jpg)
Please wait processing your request...